Skip to main content
SpringerLink
Log in

Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The cardiac arrhythmia is characterized by irregular rhythm of heartbeat which could be either too slow (<60 beats/min) or too fast (>100 beats/min) and can happen at any age. The use of pacemaker and defibrillators devices has been suggested for heart arrhythmias patients. The antiarrhythmic medications have been reported for the treatment of cardiac arrhythmias or irregular heartbeats. The diagnosis, symptoms, and treatments of cardiac arrhythmias as well as the radiofrequency ablation, tachycardia, Brugada syndrome, arterial fibrillation, and recent research on the genetics of cardiac arrhythmias have been described here.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cleveland Clinic. (2014). ECG of cardiac arrhythmias. Ohio: Cleveland Clinic. www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiacarrhythmias/2014.

  2. Hook, B. G., & Marchlinski, F. E. (1991). Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. Journal of the American College of Cardiology, 17(4), 978–984. doi:10.1016/0735-1097(91)90884-C.

    Article  Google Scholar 

  3. The New York Times. (2014, July 23). Arrhythmias treatment.

  4. Gregoratos, G., Abrams, J., Epstein, A. E., & American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. (1998). A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation, 106, 2145–2161.

    Article  Google Scholar 

  5. Zipes, D. P., Wyse, G., Friedman, P. L., et al. (1997). A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine, 337, 1576–1583.

    Article  Google Scholar 

  6. Mushlin, A. I., Hall, W. J., Zwanziger, J., Multicenter Automatic Defibrillator Implantation Trial, et al. (1998). The cost-effectiveness of automatic implantable cardiac defibrillators: Results of MADIT. Circulation, 97, 2129–2135.

    Article  CAS  PubMed  Google Scholar 

  7. Moss, A. J., Zareba, W., Hall, J., Multicenter Automatic Defibrillator Implantation Trial II Investigators, et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346, 877–888.

    Article  PubMed  Google Scholar 

  8. Wilkoff, B. L., Cook, J. R., Epstein, A. E., Dual Chamber and VVI Implantable Defibrillator Trial Investigators, et al. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, 288, 3115–3123.

    Article  PubMed  Google Scholar 

  9. Abraham, W. T., Fisher, W. G., Smith, A. L., et al. (2002). Cardiac resynchronization in chronic heart failure. New England Journal of Medicine, 346, 1845–1853.

    Article  PubMed  Google Scholar 

  10. Zipes, D. P., DiMarco, J. P., Jackman, W. M., et al. (1995). Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. Journal of the American College of Cardiology, 26, 555–573.

    Article  CAS  PubMed  Google Scholar 

  11. Tracy, C. M., Masood, A., DiMarco, J. P., et al. (2000). ACC/AHA clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion. Journal of the American College of Cardiology, 36, 1725–1736.

    Article  CAS  PubMed  Google Scholar 

  12. Calkins, H., Sousa, J., El-Atassi, R., et al. (1991). Diagnosis and cure of the Wolff–Parkinson–White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. New England Journal of Medicine, 324, 1612–1618.

    Article  CAS  PubMed  Google Scholar 

  13. Jackman, W., Wang, X., Friday, K. J., et al. (1991). Catheter ablation of accessory atrioventricular pathways (Wolff–Parkinson–White syndrome) by radiofrequency current. New England Journal of Medicine, 324, 1604–1611.

    Article  Google Scholar 

  14. Marrouche, N. F., Dresing, T., Cole, C., et al. (2002). A circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: Impact of different catheter technologies. Journal of the American College of Cardiology, 40, 464–474.

    Article  PubMed  Google Scholar 

  15. Wyse, D. G., Waldo, A. L., DiMarco, J. P., Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators, et al. (2002). A comparison of rate control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine, 347, 1825–1833.

    Article  CAS  PubMed  Google Scholar 

  16. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. (1989). Preliminary report: Effect of encainide and flecainide on mortality in a randomized trail of arrhythmia suppression after myocardial infarction. New England Journal of Medicine, 321, 406–412.

    Article  Google Scholar 

  17. Chaudhry, G., Muqtada, M. D., & Haffajee, C. I. (2000). Antiarrhythmic agents and proarrhythmia. Critical Care Medicine, 28, N158–N164.

    Article  CAS  PubMed  Google Scholar 

  18. Coplen, S. E., Antman, E. M., Berlin, J. A., et al. (1990). Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation, 82, 1106–1116.

    Article  CAS  PubMed  Google Scholar 

  19. Kanagaratnam, L., Tomassoni, G., Schweikert, R., et al. (2001). Ventricular tachycardias arising from the aortic sinus of Valsalva: An under-recognized variant of left outflow tract ventricular tachycardia. Journal of the American College of Cardiology, 37, 1408–1414.

    Article  CAS  PubMed  Google Scholar 

  20. Wilkoff, B. L. (2006). Pacemaker and ICD malfunction—an incomplete picture. JAMA, 295, 1945–1946.

    Article  Google Scholar 

  21. Rajamani, K., Goldberg, A. S., & Wilkoff, B. L. (2014). Shock avoidance and the newer tachycardia therapy algorithms. Cardiology Clinics, 32(2), 191–200. doi:10.1016/j.ccl.2014.01.002.

    Article  PubMed  Google Scholar 

  22. Bardy, G. H., Lee, K. L., Mark, D. B., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators, et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352, 225–237.

    Article  CAS  PubMed  Google Scholar 

  23. Benditt, D., Ferguson, D., Grubb, B., et al. (1996). Tilt testing for assessing syncope. Journal of the American College of Cardiology, 28, 263–275.

    Article  CAS  PubMed  Google Scholar 

  24. Buxton, A. E., Lee, K. L., Fisher, J. D., et al. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease. New England Journal of Medicine, 341, 1882–1890.

    Article  CAS  PubMed  Google Scholar 

  25. Kadish, A., Dyer, A., Daubert, J. P., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators, et al. (2004). Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New England Journal of Medicine, 350, 2151–2158.

    Article  CAS  PubMed  Google Scholar 

  26. Hoek, G., Brunekreef, B., Fischer, P., & van Wijnen, J. (2001). The Association between air pollution and heart failure, arrhythmia, embolism, thrombosis, and other cardiovascular causes of death in a time series study brief report. Epidemiology, 12(3), 355–357.

    Article  CAS  PubMed  Google Scholar 

  27. Liew, R. (2014). Almanac 2013: Cardiac arrhythmias and pacing-an editorial overview of selected research that has driven recent advances in clinical cardiology. Acta Cardiology, 69(2), 222–234.

    Google Scholar 

  28. Kuck, K. H., & Hindricks, G. (2014). The year in cardiology 2013: Arrhythmias. European Heart Journal, 35(8), 485–490. doi:10.1093/eurheartj/eht552.

    Article  Google Scholar 

  29. Fogorus, R. N. (2014, Dec 16). Medications for heart arrhythmias, heart disease expert. Free email Letter (www.LetAbout.com), Medical Review Board, Tom Grill Images.

  30. Bigger, J. T., Günter, B., Brown, A. M., Camm, A. J., Carmeliet, E., & Fozzard, H. A. (1991). The Sicilian Gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on Arrhythmogenic mechanisms. Task force of the Working Group on Arrythmias. European Society of Cardiology, 84, 1831.

  31. Sagara, K. (2014). Ventriculo-ventri-cular delay optimization of a cardiac resynchro-nization device. Journal of Arrythmia, 30(6), 413–416. doi:10.1016/j.joa.2014.03.013.

    Article  Google Scholar 

  32. Norishige, M., Mandel, W. J., Kobayashi, Y., & Karagueuzian, H. S. (2014). Cardiac fibrosis as a determinant of ventricular tachyarrhythmias. Journal of Arrythmia, 30(6), 389–394. doi:10.1016/j.joa.2013.12.008.

    Article  Google Scholar 

  33. Sinner, M. F. et al. (2014). Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation, 130, 1225–1235. doi:10.1161/CirculationAHA.114.009892.

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Xiangyang Hospital Affiliated to Hubei University of Medicine, Xiangyang, 441000, Hubei, People’s Republic of China

    Du-guan Fu

Authors
  1. Du-guan Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Du-guan Fu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fu, Dg. Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments. Cell Biochem Biophys 73, 291–296 (2015). https://doi.org/10.1007/s12013-015-0626-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-015-0626-4

Keywords

Search

Navigation